Cancer Research SABCS  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robertson, N.
Right arrow Articles by Harris, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, N.
Right arrow Articles by Harris, A. L.
[Cancer Research 64, 6160-6165, September 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion

Naomi Robertson, Christian Potter and Adrian L. Harris

Cancer Research UK, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

Carbonic anhydrase IX (CAIX) is a membrane-associated carbonic anhydrase (CA), strongly induced by hypoxia. CAIX is overexpressed in a variety of tumor types and associated with increased metastasis and poor prognosis. An inhibitor of CAs, acetazolamide has been reported to inhibit invasion. We used RNA interference (RNAi) to examine the function of CAIX in MDA468 and MDA231 breast carcinoma cells, which express high levels of CAIX under hypoxia. Hypoxia-induced CA activity was completely blocked by specific RNAi (P < 0.01). RNAi-treated cells showed growth delay in dense monolayer culture and a 50% reduction in clonogenic survival under hypoxia. In the MDA468 cells, there was no effect of RNAi treatment on invasion. In a cell line that did not induce CAIX under hypoxia, RT112, we found no effect on the ability of cells transfected with CAIX to invade or migrate. Thus, CAIX plays an important role in the growth and survival of tumor cells under normoxia and hypoxia, making it a potential target for cancer therapy, but is not involved in invasion.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. van den Beucken, M. Koritzinsky, H. Niessen, L. Dubois, K. Savelkouls, H. Mujcic, B. Jutten, J. Kopacek, S. Pastorekova, A. J. van der Kogel, et al.
Hypoxia-induced Expression of Carbonic Anhydrase 9 Is Dependent on the Unfolded Protein Response
J. Biol. Chem., September 4, 2009; 284(36): 24204 - 24212.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chiche, K. Ilc, J. Laferriere, E. Trottier, F. Dayan, N. M. Mazure, M. C. Brahimi-Horn, and J. Pouyssegur
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Cancer Res., January 1, 2009; 69(1): 358 - 368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Swietach, S. Wigfield, P. Cobden, C. T. Supuran, A. L. Harris, and R. D. Vaughan-Jones
Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths
J. Biol. Chem., July 18, 2008; 283(29): 20473 - 20483.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. J. Brennan, K. Jirstrom, A. Kronblad, R. C. Millikan, G. Landberg, M. J. Duffy, L. Ryden, W. M. Gallagher, and S. L. O'Brien
CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance.
Clin. Cancer Res., November 1, 2006; 12(21): 6421 - 6431.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. M. Hammond and A. J. Giaccia
Hypoxia-Inducible Factor-1 and p53: Friends, Acquaintances, or Strangers?
Clin. Cancer Res., September 1, 2006; 12(17): 5007 - 5009.
[Full Text] [PDF]


Home page
Cancer Res.Home page
D. T. Jones, I. S. Trowbridge, and A. L. Harris
Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
Cancer Res., March 1, 2006; 66(5): 2749 - 2756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Patel, J.-L. Li, D. Generali, R. Poulsom, D. W. Cranston, and A. L. Harris
Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function
Cancer Res., October 1, 2005; 65(19): 8690 - 8697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.